{{Rsnum
|rsid=11821102
|Gene=CD44
|Chromosome=11
|position=35230997
|Orientation=plus
|GMAF=0.07851
|Gene_s=CD44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 7.1 | 92.9
| HCB | 1.5 | 8.0 | 90.5
| JPT | 1.8 | 23.0 | 75.2
| YRI | 2.7 | 26.7 | 70.5
| ASW | 3.5 | 40.4 | 56.1
| CHB | 1.5 | 8.0 | 90.5
| CHD | 0.0 | 15.6 | 84.4
| GIH | 0.0 | 7.9 | 92.1
| LWK | 0.0 | 30.3 | 69.7
| MEX | 0.0 | 5.2 | 94.8
| MKK | 0.0 | 25.0 | 75.0
| TSI | 0.0 | 5.9 | 94.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=22788972
|Title=CD44 rs13347 C&gt;T polymorphism predicts breast cancer risk and prognosis in Chinese populations
|OA=1
}}

{{PMID Auto
|PMID=23883608
|Title=Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}